AllianceBernstein’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $91.3M | Sell |
1,455,619
-170,166
| -10% | -$9.24M | 0.03% | 422 |
|
|
2026
Q1 | $155M | Sell |
1,625,785
-1,174,944
| -42% | -$94M | 0.05% | 256 |
|
|
2025
Q4 | $267M | Sell |
2,800,729
-185,749
| -6% | -$18.2M | 0.08% | 179 |
|
|
2025
Q3 | $292M | Sell |
2,986,478
-302,058
| -9% | -$31.3M | 0.09% | 171 |
|
|
2025
Q2 | $353M | Buy |
3,288,536
+251,601
| +8% | +$25.5M | 0.12% | 146 |
|
|
2025
Q1 | $306M | Buy |
3,036,935
+1,189,016
| +64% | +$120M | 0.11% | 152 |
|
|
2024
Q4 | $165M | Buy |
1,847,919
+110,934
| +6% | +$9.77M | 0.06% | 255 |
|
|
2024
Q3 | $146M | Sell |
1,736,985
-77,725
| -4% | -$6.13M | 0.05% | 291 |
|
|
2024
Q2 | $140M | Buy |
1,814,710
+16,819
| +0.9% | +$1.23M | 0.05% | 285 |
|
|
2024
Q1 | $123M | Sell |
1,797,891
-167,041
| -9% | -$10.7M | 0.04% | 355 |
|
|
2023
Q4 | $114M | Sell |
1,964,932
-26,330
| -1% | -$1.41M | 0.04% | 368 |
|
|
2023
Q3 | $105M | Sell |
1,991,262
-94,519
| -5% | -$4.96M | 0.04% | 363 |
|
|
2023
Q2 | $113M | Sell |
2,085,781
-5,695
| -0.3% | -$297K | 0.05% | 361 |
|
|
2023
Q1 | $105M | Sell |
2,091,476
-78,632
| -4% | -$3.71M | 0.04% | 375 |
|
|
2022
Q4 | $100M | Buy |
2,170,108
+174,338
| +9% | +$7.55M | 0.05% | 378 |
|
|
2022
Q3 | $77.3M | Buy |
1,995,770
+256,758
| +15% | +$10.3M | 0.04% | 425 |
|
|
2022
Q2 | $64.8M | Sell |
1,739,012
-11,823
| -0.7% | -$481K | 0.03% | 490 |
|
|
2022
Q1 | $77.5M | Buy |
1,750,835
+43,695
| +3% | +$1.89M | 0.03% | 476 |
|
|
2021
Q4 | $72.5M | Sell |
1,707,140
-177,432
| -9% | -$7.46M | 0.03% | 517 |
|
|
2021
Q3 | $81.8M | Buy |
1,884,572
+83,571
| +5% | +$3.7M | 0.03% | 486 |
|
|
2021
Q2 | $77M | Sell |
1,801,001
-281,324
| -14% | -$11.8M | 0.03% | 509 |
|
|
2021
Q1 | $80.5M | Buy |
2,082,325
+81,544
| +4% | +$3.09M | 0.04% | 469 |
|
|
2020
Q4 | $71.9M | Sell |
2,000,781
-2,548,226
| -56% | -$91.8M | 0.03% | 470 |
|
|
2020
Q3 | $174M | Sell |
4,549,007
-403,176
| -8% | -$15.5M | 0.09% | 186 |
|
|
2020
Q2 | $174M | Sell |
4,952,183
-1,395,280
| -22% | -$50.2M | 0.1% | 172 |
|
|
2020
Q1 | $207M | Sell |
6,347,463
-451,623
| -7% | -$17.6M | 0.15% | 131 |
|
|
2019
Q4 | $307M | Sell |
6,799,086
-257,632
| -4% | -$10.8M | 0.17% | 120 |
|
|
2019
Q3 | $287M | Sell |
7,056,718
-393,372
| -5% | -$16.7M | 0.18% | 112 |
|
|
2019
Q2 | $320M | Buy |
7,450,090
+361,494
| +5% | +$13.9M | 0.2% | 104 |
|
|
2019
Q1 | $272M | Sell |
7,088,596
-579,444
| -8% | -$22.1M | 0.18% | 116 |
|
|
2018
Q4 | $271M | Buy |
7,668,040
+1,238,771
| +19% | +$44.9M | 0.2% | 106 |
|
|
2018
Q3 | $248M | Buy |
6,429,269
+1,268,172
| +25% | +$44.3M | 0.16% | 131 |
|
|
2018
Q2 | $169M | Buy |
5,161,097
+2,849,915
| +123% | +$86M | 0.12% | 175 |
|
|
2018
Q1 | $63.1M | Buy |
2,311,182
+84,328
| +4% | +$2.29M | 0.05% | 429 |
|
|
2017
Q4 | $55.2M | Sell |
2,226,854
-53,043
| -2% | -$1.46M | 0.04% | 462 |
|
|
2017
Q3 | $66.5M | Buy |
2,279,897
+32,367
| +1% | +$894K | 0.05% | 410 |
|
|
2017
Q2 | $62.3M | Sell |
2,247,530
-50,585
| -2% | -$1.34M | 0.05% | 420 |
|
|
2017
Q1 | $57.2M | Buy |
2,298,115
+23,022
| +1% | +$560K | 0.05% | 436 |
|
|
2016
Q4 | $49.2M | Sell |
2,275,093
-78,111
| -3% | -$1.7M | 0.04% | 455 |
|
|
2016
Q3 | $56M | Buy |
2,353,204
+10,076
| +0.4% | +$240K | 0.05% | 426 |
|
|
2016
Q2 | $54.8M | Sell |
2,343,128
-22,641
| -1% | -$490K | 0.05% | 400 |
|
|
2016
Q1 | $44.5M | Sell |
2,365,769
-12,980
| -0.5% | -$228K | 0.04% | 455 |
|
|
2015
Q4 | $43.9M | Sell |
2,378,749
-50,447
| -2% | -$904K | 0.04% | 476 |
|
|
2015
Q3 | $39.9M | Sell |
2,429,196
-19,415
| -0.8% | -$332K | 0.03% | 486 |
|
|
2015
Q2 | $43.3M | Sell |
2,448,611
-37,365
| -2% | -$668K | 0.04% | 513 |
|
|
2015
Q1 | $44.1M | Sell |
2,485,976
-78,838
| -3% | -$1.25M | 0.04% | 512 |
|
|
2014
Q4 | $34M | Sell |
2,564,814
-28,714
| -1% | -$367K | 0.03% | 566 |
|
|
2014
Q3 | $30.6M | Buy |
2,593,528
+5,294
| +0.2% | +$66.7K | 0.03% | 590 |
|
|
2014
Q2 | $33.1M | Sell |
2,588,234
-304,389
| -11% | -$3.96M | 0.03% | 570 |
|
|
2014
Q1 | $39.1M | Buy |
2,892,623
+191,910
| +7% | +$2.52M | 0.03% | 522 |
|
|
2013
Q4 | $32.5M | Sell |
2,700,713
-44,060
| -2% | -$521K | 0.03% | 549 |
|
|
2013
Q3 | $32.2M | Buy |
2,744,773
+114,744
| +4% | +$1.24M | 0.03% | 529 |
|
|
2013
Q2 | $24.4M | Buy |
+2,630,029
| New | +$22.3M | 0.03% | 596 |
|
Other funds holding BSX
AllianceBernstein's BSX Position: Q2 2026 in Review
AllianceBernstein reduced its Boston Scientific (BSX) stake by 10% in Q2 2026, selling an estimated $9.24M and leaving 1,455,619 shares worth $91.3M. The position accounts for 0.03% of the portfolio, ranked #422.
AllianceBernstein first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $353M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- AllianceBernstein held 1,455,619 shares of Boston Scientific worth $91.3M as of Q2 2026.
- AllianceBernstein sold 170,166 Boston Scientific shares in Q2 2026, an estimated $9.24M.
- Boston Scientific made up 0.03% of AllianceBernstein's portfolio in Q2 2026, its #422 holding.
- AllianceBernstein first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- AllianceBernstein's Boston Scientific position peaked at $353M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.